Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Serotype replacement after pneumococcal vaccination.

Hausdorff WP, Van Dyke MK, Van Effelterre T.

Lancet. 2012 Apr 14;379(9824):1387-8; author reply 1388-9. doi: 10.1016/S0140-6736(12)60589-3. No abstract available.

PMID:
22500868
2.

Why it is still important that countries know the burden of pneumococcal disease.

Prato R, Tafuri S, Fortunato F, Martinelli D.

Hum Vaccin. 2010 Nov;6(11):918-21. Review. No abstract available.

PMID:
21045538
3.

The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.

Black S.

Pediatr Infect Dis J. 2010 Apr;29(4):301-3. doi: 10.1097/INF.0b013e3181c391fb. Review. No abstract available.

PMID:
19935444
4.

Serotype-specific problems associated with pneumococcal conjugate vaccination.

Hanage WP.

Future Microbiol. 2008 Feb;3(1):23-30. doi: 10.2217/17460913.3.1.23. Review.

PMID:
18230031
5.

Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination.

Mehr S, Wood N.

Paediatr Respir Rev. 2012 Dec;13(4):258-64. doi: 10.1016/j.prrv.2011.12.001. Review.

PMID:
23069126
6.

Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.

Rodgers GL, Arguedas A, Cohen R, Dagan R.

Vaccine. 2009 Jun 12;27(29):3802-10. doi: 10.1016/j.vaccine.2009.04.021. Review.

PMID:
19446378
7.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

8.

Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines.

Ansaldi F, de Florentis D, Canepa P, Bandettini R, Diana MC, Martini M, Durando P, Icardi G.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:211-6. doi: 10.4161/hv.7.0.14602. Review.

PMID:
21546795
9.

Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review.

Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC.

Vaccine. 2012 May 21;30(24):3503-14. doi: 10.1016/j.vaccine.2012.03.066. Review.

PMID:
22475858
10.

Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.

Reinert R, Jacobs MR, Kaplan SL.

Vaccine. 2010 Jun 11;28(26):4249-59. doi: 10.1016/j.vaccine.2010.04.020. Review.

PMID:
20416266
11.

Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.

Picazo JJ.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Review.

12.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Review.

PMID:
18378430
13.

Pneumococcal vaccine.

Peter G, Klein JO.

Pediatr Rev. 1996 Oct;17(10):335-41; quiz 342. Review. No abstract available. Erratum in: Pediatr Rev 1996 Dec;17(12):425.

PMID:
8885640

Supplemental Content

Support Center